SEC Form 4 · accession 0001104659-26-103210
Orchestra BioMed Holdings, Inc. · OBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew Lawrence Taylor
Officer — Chief Financial Officer
Period of report
Aug 26, 2026
Accepted (ET)
Aug 28, 2026 · 4:16 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001814114
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per share | Aug 26, 2026 | F | 3,076 | $5.26 | D | 589,989 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units ("RSUs"). No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations.